Medindia
Medindia LOGIN REGISTER
Advertisement

Update on Allscripts-Misys Transaction

Wednesday, September 17, 2008 General News
Advertisement
CHICAGO, Sept. 16 Allscripts HealthcareSolutions, Inc. ("Allscripts") (Nasdaq: MDRX), the leading provider ofclinical software, connectivity and information solutions that physicians useto improve healthcare, announced today that Misys plc ("Misys") has issued apress release regarding recent events at Lehman Brothers. In connection withthe proposed transactions contemplated by an Agreement and Plan of Mergerdated as of March 17, 2008 by and among Allscripts, Misys, Misys HealthcareSystems, LLC ("MHS") and Patriot Merger Company, LLC (the "Merger Agreement"),Lehman Brothers committed to a $305 million term and revolving credit facilityagreement dated March 19, 2008 (as amended and restated on July 22, 2008) withMisys in order to fund a portion of the $330 million payment by Misys toAllscripts contemplated by the Merger Agreement.
Advertisement

(Logo: http://www.newscom.com/cgi-bin/prnh/20061005/ALLSCRIPTSLOGO-b)

Misys has stated that it has been unable to confirm whether LehmanBrothers will be able to fulfill its role under this facility and hastherefore commenced the process of identifying other funding alternatives andis in discussions with several other debt providers. The consummation of thetransactions contemplated by the Merger Agreement is not subject to afinancing condition.
Advertisement

Given the circumstances, Allscripts intends to adjourn its 2008 annualmeeting of stockholders scheduled for Monday, September 22, 2008 to October 6,2008, the same date to which Misys has determined to adjourn its extraordinarygeneral meeting. Allscripts continues to support the transactionscontemplated by the Merger Agreement, and is working together with Misys tobring the transactions to a successful conclusion. Glen Tullman, ChiefExecutive Officer of Allscripts, added, "While the events surrounding LehmanBrothers are unfortunate, we nevertheless remain excited about thetransactions with Misys and believe they are in the best interests of ourstockholders and clients."

About Allscripts

Allscripts (Nasdaq: MDRX) is the leading provider of clinical software,connectivity and information solutions that physicians use to improvehealthcare. The company's unique solutions inform, connect and transformhealthcare, delivering improved care at lower cost. More than 40,000physicians and thousands of other healthcare professionals in clinics,hospitals and extended care facilities nationwide utilize Allscripts toautomate everyday tasks such as writing prescriptions, documenting patientcare, managing billing and scheduling, and safely discharging patients, aswell as to connect with key information and stakeholders in the healthcaresystem. To learn more, visit Allscripts at http://www.allscripts.com.

Forward-Looking Statements

This communication contains forward-looking statements. Thoseforward-looking statements include all statements other than those made solelywith respect to historical fact. Forward-looking statements may be identifiedby words such as "believes", "expects", "anticipates", "estimates","projects", "intends", "should", "seeks", "future", continue", or the negativeof such terms, or other comparable terminology. Such statements include, butare not limited to, statements about the expected benefits of the transactioninvolving Allscripts, Misys Healthcare Systems, LLC ("MHS") and Misys plc("Misys"), including potential synergies and cost savings, future financialand operating results, and the combined company's plans and objectives. Inaddition, statements made in this communication about anticipated financialresults, future operational improvements and results or conditions andapprovals are also forward-looking statements. Such forward-lookingstatements are subject to numerous risks, uncertainties, assumptions and otherfactors that are difficult to predict and that could cause actual results tovary materially from those expressed in o
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close